Clinical trial
Antihyperlipidemic Effects of Oyster Mushrooms
NCT00069524 · National Center for Complementary and Integrative Health (NCCIH), NIH · Completed
Key facts
| NCT number | NCT00069524 |
|---|---|
| Title | Antihyperlipidemic Effects of Oyster Mushrooms |
| Official title | Antihyperlipidemic Effects of Oyster Mushrooms |
| Lead sponsor | National Center for Complementary and Integrative Health (NCCIH), NIH |
| Collaborators | Office of Dietary Supplements (ODS) NIH |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | HIV Infections, Hyperlipidemia |
| Intervention type | Drug |
| Interventions | oyster mushroom |
| Enrollment | 20 |
| Start date | Jun 1, 2004 |
| Completion | May 1, 2006 |
| First posted | Oct 1, 2003 |
| Last update posted | Sep 26, 2007 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: